Gene expression analysis of follicular cells revealed inflammation as a potential IVF failure cause.


Journal

Journal of assisted reproduction and genetics
ISSN: 1573-7330
Titre abrégé: J Assist Reprod Genet
Pays: Netherlands
ID NLM: 9206495

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 15 10 2018
accepted: 29 03 2019
pubmed: 20 4 2019
medline: 18 12 2019
entrez: 20 4 2019
Statut: ppublish

Résumé

Hormonal stimulation prior to IVF influences the ovarian environment and therefore impacts oocytes and subsequent embryo quality. Not every patient has the same response to the same treatment and many fail for unknown reasons. Knowing why a cycle has failed and how the follicles were affected would allow clinicians to adapt the treatment accordingly and improve success rate. This study examines the hypothesis that transcriptomic analysis of follicular cells from failed IVF cycles reveals potential reasons for failure and provides new information on the physiological mechanisms related to IVF failure. Follicular cells (granulosa cells) were obtained from IVF patients of four Canadian fertility clinics. Using microarray analysis, patients that did not become pregnant following the IVF cycle were compared to those that did. Functional analysis was performed using ingenuity pathway analysis and qRT-PCR was used to validate the microarray results in a larger cohort of patients. The microarray showed 165 differentially expressed genes (DEGs) in the negative group compared to the pregnancy group. DEGs include many pro-inflammatory cytokines and other factors related to inflammation, suggesting that this process might be altered when IVF fails. Overexpression of several factors, some of which act upstream from vascular endothelial growth factor (VEGF), also indicates increased permeability and vasodilation. Some DEGs were related to abnormal differentiation and increased apoptosis. Our results suggest that failure to conceive following IVF cycles could be associated with an imbalance between pro-inflammatory and anti-inflammatory mediators. The findings of this study identify potential failure causes and pathways for further investigation. Stimulatory protocols personalized according to patient response could improve the chances of later success.

Identifiants

pubmed: 31001707
doi: 10.1007/s10815-019-01447-4
pii: 10.1007/s10815-019-01447-4
pmc: PMC6603252
doi:

Substances chimiques

VEGFA protein, human 0
Vascular Endothelial Growth Factor A 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1195-1210

Subventions

Organisme : EMD Serono (US)
ID : GFI (grant for fertility innovation)

Références

Nat Commun. 2013;4:1759
pubmed: 23612300
J Immunol. 1995 Aug 1;155(3):1428-33
pubmed: 7636208
Hum Reprod. 2008 May;23(5):1118-27
pubmed: 18310048
Ann N Y Acad Sci. 2006 Dec;1092:247-64
pubmed: 17308149
Science. 2003 Jan 10;299(5604):223-6
pubmed: 12522243
Cell Death Dis. 2012 Nov 29;3:e433
pubmed: 23190605
Genomics. 2001 Nov;78(1-2):99-106
pubmed: 11707078
FASEB J. 2001 Dec;15(14):2757-9
pubmed: 11606484
Neurochem Int. 1997 Oct;31(4):477-510; discussion 517-6
pubmed: 9307998
Mol Hum Reprod. 2006 Jan;12(1):1-6
pubmed: 16439481
Fertil Steril. 2013 Mar 1;99(3):745-752.e6
pubmed: 23200692
Biochemistry. 2010 Mar 9;49(9):1923-30
pubmed: 20121050
Biol Reprod. 1980 Feb;22(1):73-106
pubmed: 6991013
Genome Biol. 2002 Jun 18;3(7):RESEARCH0034
pubmed: 12184808
Endocrinology. 1998 May;139(5):2501-8
pubmed: 9564864
Hum Reprod. 1997 Oct;12(10):2143-6
pubmed: 9402270
Reprod Biomed Online. 2015 Apr;30(4):426-33
pubmed: 25682305
Matrix Biol. 1998 Feb;16(7):387-98
pubmed: 9524359
Mol Hum Reprod. 2010 Feb;16(2):87-96
pubmed: 19778949
Reproduction. 2009 May;137(5):843-55
pubmed: 19225042
Fertil Steril. 1994 Mar;61(3):488-95
pubmed: 8137972
Mol Hum Reprod. 2010 Aug;16(8):548-56
pubmed: 20610614
Mol Hum Reprod. 2016 Jul;22(7):475-84
pubmed: 27126491
PLoS One. 2013;8(4):e54226
pubmed: 23573182
FASEB J. 2003 Oct;17(13):1937-9
pubmed: 12897063
Hum Reprod. 1998 Sep;13(9):2406-10
pubmed: 9806258
Lancet. 1994 Jul 23;344(8917):235-6
pubmed: 7913160
Best Pract Res Clin Obstet Gynaecol. 2009 Oct;23(5):691-709
pubmed: 19632900
Science. 2002 Jun 21;296(5576):2178-80
pubmed: 12077402
J Clin Invest. 1985 Nov;76(5):2003-11
pubmed: 3877078
Exp Mol Med. 2004 Feb 29;36(1):1-12
pubmed: 15031665
Mol Hum Reprod. 2008 Dec;14(12):711-9
pubmed: 19028806
J Soc Gynecol Investig. 2000 Jan-Feb;7(1):51-60
pubmed: 10732316
Cancer Res. 2013 Jan 15;73(2):583-94
pubmed: 23188504
Biochem Biophys Res Commun. 1995 Feb 6;207(1):25-32
pubmed: 7857273
J Leukoc Biol. 2011 Nov;90(5):855-65
pubmed: 21562052
Br Med Bull. 1997;53(3):669-83
pubmed: 9374045
C R Seances Soc Biol Fil. 1995;189(4):531-44
pubmed: 8564567
Biochem Biophys Res Commun. 2004 Jul 9;319(4):1181-9
pubmed: 15194491
Hum Reprod Update. 1997 May-Jun;3(3):255-66
pubmed: 9322101
J Assist Reprod Genet. 1992 Oct;9(5):429-38
pubmed: 1482837
Fertil Steril. 2011 Jul;96(1):47-52.e2
pubmed: 21575950
PLoS One. 2012;7(7):e40449
pubmed: 22848380
Hum Reprod Update. 2008 Jul-Aug;14(4):321-33
pubmed: 18385260
Nat Med. 2000 Dec;6(12):1355-61
pubmed: 11100120
Reproduction. 2001 Dec;122(6):829-38
pubmed: 11732978
J Assist Reprod Genet. 2011 Feb;28(2):173-88
pubmed: 20953827
J Clin Endocrinol Metab. 2016 Sep;101(9):3459-68
pubmed: 27228368
J Mol Med (Berl). 1998 Aug;76(9):613-6
pubmed: 9725763
Hum Reprod. 1996 Jul;11(7):1377-80
pubmed: 8671470
J Clin Invest. 2002 Jan;109(1):41-50
pubmed: 11781349
Eye (Lond). 2009 Jan;23(1):222-9
pubmed: 18535602
Am J Pathol. 1985 Dec;121(3):394-403
pubmed: 3878084
Nat Rev Immunol. 2007 Sep;7(9):678-89
pubmed: 17717539
J Exp Med. 1993 Dec 1;178(6):2207-11
pubmed: 8245792
Nature. 1997 Nov 27;390(6658):350-1
pubmed: 9389474
Hum Reprod. 2016 Aug;31(8):1638-52
pubmed: 27496943
Immunol Today. 1988 May;9(5):137-9
pubmed: 3076767
J Immunol. 2003 Jan 15;170(2):1027-33
pubmed: 12517970
Cell Death Differ. 1999 Jan;6(1):3-5
pubmed: 10200541
Am J Respir Crit Care Med. 2001 Mar;163(3 Pt 1):778-85
pubmed: 11254538
Fertil Steril. 2013 Mar 15;99(4):979-97
pubmed: 23498999
Reproduction. 2009 Oct;138(4):629-37
pubmed: 19602522
Immunity. 2014 Nov 20;41(5):694-707
pubmed: 25517612
World J Surg. 1996 May;20(4):437-46
pubmed: 8662132
Cell. 2010 Mar 19;140(6):771-6
pubmed: 20303867
J Clin Endocrinol Metab. 2012 Oct;97(10):E2016-21
pubmed: 22904171

Auteurs

Chloé S Fortin (CS)

Centre de recherche en reproduction, développement et santé intergénérationnelle (CRDSI), Université Laval, 2440 Boulevard Hochelaga, Québec, QC, G1V 0A6, Canada.

Arthur Leader (A)

Ottawa Fertility Centre, 100-955 Green Valley Crescent, Ottawa, ON, K2C 3V4, Canada.

Neal Mahutte (N)

Montréal Fertility Centre, 5252 de Maisonneuve Boulevard West Suite 220, Montréal, QC, H4A 3S5, Canada.

Scot Hamilton (S)

Reproductive Care Centre, 2180 Meadowvale Boulevard, Toronto, ON, L5N 5S3, Canada.

Marie-Claude Léveillé (MC)

Ottawa Fertility Centre, 100-955 Green Valley Crescent, Ottawa, ON, K2C 3V4, Canada.

Marc Villeneuve (M)

PROCREA Cliniques, 5600 Boulevard des Galeries, Québec, QC, G2K 2H6, Canada.

Marc-André Sirard (MA)

Centre de recherche en reproduction, développement et santé intergénérationnelle (CRDSI), Université Laval, 2440 Boulevard Hochelaga, Québec, QC, G1V 0A6, Canada. Marc-Andre.Sirard@fsaa.ulaval.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH